-(1)-3.jpg){kind=logo}
UMB will host the third International Conference of the Society for Interdisciplinary Placebo Studies (SIPS), “Harnessing Placebo Mechanisms for Optimal Pain Management and Treatment of Alcohol and Other Drug Use Disorders," virtually, May 26-28. The cost to attend is $15 for UMB affiliated faculty, staff, and students.
Expert faculty from UMB's Schools of Medicine, Nursing, and Pharmacy have collaborated with SIPS to design an interdisciplinary, international scientific conference to advance the science of placebo research and mind-body mechanisms and to apply this knowledge to alcohol use and pain disorders.
The conference will provide a collaborative platform to present and share innovative research findings and theoretical ideas on placebo research to an international audience of researchers; promote training and education of trainees, academic junior researchers, health care professionals, agencies, stakeholders, and the public; and advocate for the participation of minorities and women while expanding U.S. research in the global network of placebo research.
The program will include:
- Seven plenary sessions
- Three special sessions on COVID-19, placebo methodology, and virtual reality
- Over 20 workshops
- Peer-reviewed short oral presentations
- Peer-reviewed poster sessions
- Networking forums
Continuing education credit will be available for physicians, nurses, and pharmacists.
Presentations to include Plenary lecture 4: Sharing online clinical notes with patients: Implications for placebo and nocebo effects by Charlotte Blease, PhD, Keane OpenNotes Scholar, Beth Israel Deaconess Medical Center, Harvard Medical School. With an introduction by Stephen Davis, MBBS, FRCP, FACE, MACP, professor and chair, Department of Medicine, University of Maryland School of Medicine; director, Institute for Clinical and Translational Research; vice president of Clinical Translational Science, University of Maryland, Baltimore.
Blease’s background is in philosophy of medicine and science, and interdisciplinary health research. Her current work focuses on the ethics and relational benefits of note sharing, including in mental health contexts. Her wider research interests are diverse. She has researched and published on conceptual, methodological, and ethical issues pertaining to placebo studies. Other research interests include artificial intelligence and machine learning, and the future of primary care, and she is writing a book-length treatment on the subject for Yale University Press. She is a founding member of the Society for Interdisciplinary Placebo Studies, and enjoys collaborations with placebo researchers in the U.S. and Europe. Blease is the author of over 70 papers spanning philosophical and ethical aspects of health care and medical internet research.